Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma

NCT03801668 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

294

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

DRUG: Albumin-bound Paclitaxel plus S-1
DRUG: Oxaliplatin plus S-1

Sponsor

Huazhong University of Science and Technology

Collaborators

[object Object]